TP53 and T-cell non-Hodgkin lymphoma: Control P53/R26+/+ mice developed neoplastic lesions from both vascular (40.5%) and haematopoietic origins (54.8%)22, mainly T-cell lymphomas, at an average age of 25.5 weeks (Supplementary Table 1).